Axonics, Inc.·4

Feb 2, 5:59 PM ET

COHEN RAYMOND W 4

4 · Axonics, Inc. · Filed Feb 2, 2024

Insider Transaction Report

Form 4
Period: 2024-01-31
COHEN RAYMOND W
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2024-01-31$67.74/sh35,161$2,381,662188,835 total
  • Exercise/Conversion

    Performance-Based Restricted Stock Units

    2024-01-3121,9000 total
    From: 2024-01-31Common Stock (21,900 underlying)
  • Exercise/Conversion

    Common Stock

    2024-01-31+63,400223,996 total
  • Exercise/Conversion

    Performance-Based Restricted Stock Units

    2024-01-3141,5000 total
    From: 2024-01-31Common Stock (41,500 underlying)
Footnotes (4)
  • [F1]Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the vesting of Performance-Based Restricted Stock Units disclosed herein and the vesting of Restricted Stock Awards.
  • [F2]This transaction was executed in multiple trades at prices ranging from $67.53 to $68.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2024, and provided the reporting person remains in continuous service through January 31, 2024.
  • [F4]Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023 and provided the reporting person remains in continuous service through January 31, 2024.

Documents

2 files